Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|March 11, 2017
Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 statusSylvie Giacchetti, Anne-Sophie Hamy, Suzette Delaloge, et al.
Plos One|March 26, 2013
Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinomaFabien Reyal, David Hajage, Alexia Savignoni, et al.
Plos One|July 9, 2016
Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage PolarizationDavid Vallerand, Gérald Massonnet, Fatima Kébir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
A new model of patient tumor-derived breast cancer xenografts for preclinical assaysElisabetta Marangoni, Anne Vincent-Salomon, Nathalie Auger, et al.
Plos One|October 12, 2012
Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classificationFabien Reyal, Catherine Belichard, Roman Rouzier, et al.
Breast Cancer Research : BCR|April 10, 2007
Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entityAnne Vincent-Salomon, Nadège Gruel, Carlo Lucchesi, et al.
Bulletin Du Cancer|March 8, 2005
[Standards, Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004]Bruno Cutuli, Alain Fourquet, Elisabeth Luporsi, et al.
Genome Medicine|March 16, 2021
Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter studyCéline Callens, Keltouma Driouch, Anaïs Boulai, et al.
Cancer Research|March 1, 2005
Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing co-expressed genes--a study of 130 invasive ductal breast carcinomasFabien Reyal, Nicolas Stransky, Isabelle Bernard-Pierrot, et al.
Cancer Research|February 12, 2013
ATIP3, a novel prognostic marker of breast cancer patient survival, limits cancer cell migration and slows metastatic progression by regulating microtubule dynamicsAngie Molina, Lauriane Velot, Lydia Ghouinem, et al.
Pageof 8